WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUE DATE: December 8, 2006
Exhibit 4.20
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS,
AND ARE “RESTRICTED SECURITIES” AS THAT TERM IS DEFINED IN RULE 144 UNDER THE ACT. THE SECURITIES
MAY NOT BE SOLD, OFFERED FOR SALE, OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID
ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR UPON RECEIPT BY THE COMPANY OF AN OPINION OF
COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.
Warrant No. 120806-B
WARRANT TO PURCHASE SHARES OF COMMON STOCK
ISSUE
DATE: December 8, 2006
This certifies that Cadmus Corp, a corporation with a principal business address of 0000 Xxx
Xxxxx Xxx., #X, Xxxxxxx, XX 00000-0000 (or any valid transferee thereof, the “Holder”), for value
received, is entitled to purchase from CytoCore, Inc., a Delaware corporation with its principal
business office located at 000 Xxxxx Xxxxxxx Xxxxxx, Xxxxx 000, Xxxxxxx, Xxxxxxxx 00000 (together
with its successors and assigns, the “Company”), subject to the terms and conditions set forth
below, at any time or from time to time on and after the Issue Date as set forth above and before
3:00 p.m. (Eastern Daylight Time) on July 18, 2008 (the “Expiration Date”), 1,673,077 shares of
common stock, $.001 par value per share, of the Company (“Common Stock”), at a price of $0.10 per
share. The shares purchasable upon exercise of this Warrant, and the purchase price per share,
each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter
referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
(a) Exercise. The Holder may, at the Holder’s option, elect to exercise this Warrant,
in whole or in part, at any time or from time to time on or after the Issue Date but prior to 3:00
p.m. (Eastern Daylight Time) on the Expiration Date, by surrendering this Warrant, with the
purchase form appended hereto as Exhibit I duly executed by or on behalf of the Holder, at
the principal office of the Company, or at such other office or agency as the Company may
designate, accompanied by payment in full, in lawful money of the United States, of the Purchase
Price payable in respect of the number of Warrant Shares purchased upon such exercise. In no event
shall any such exercise be for fewer than 10,000 Warrant Shares unless fewer than an aggregate of
10,000 Warrant Shares are then purchasable under all outstanding Warrants held by the Holder.
Payment of the aggregate Purchase Price may be made in cash, certified or bank check, or wire
transfer of immediately available funds.
(b) Exercise Date and Status as Holder of Shares. Each exercise of this Warrant shall
be deemed to have been effected immediately prior to the close of business on the
day on which this Warrant shall have been surrendered to the Company as provided in Subsection
1(a) above (the “Exercise Date”). At such time, the person or persons in whose name or names any
certificates for Warrant Shares shall be issuable upon such exercise as provided in Subsection 1(c)
below shall be deemed to have become the holder or holders of record of the Warrant Shares
represented by such certificates.
(c) Issuance of Certificates. As soon as practicable after the exercise of this
Warrant in whole or in part, and in any event within 10 business days thereafter, the Company, at
its expense, will cause to be issued in the name of, and delivered to, the Holder, or as the Holder
(upon payment by the Holder of any applicable transfer taxes) may direct:
(i) a certificate or certificates for the number of full Warrant Shares to which the Holder
shall be entitled upon such exercise plus, in lieu of any fractional share to which the Holder
would otherwise be entitled, cash in an amount determined pursuant to Section 3 hereof; and
(ii) in case such exercise is in part only, a new warrant or warrants (dated the date hereof)
of like tenor, calling in the aggregate on the face or faces thereof for the number of Warrant
Shares equal (without giving effect to any adjustment therein) to the number of such shares called
for on the face of this Warrant minus the number of Warrant Shares for which this Warrant was so
exercised.
(d) Warrant Shares. The Warrant Shares issued upon any such exercise of this Warrant
shall be validly issued, fully paid and non-assessable.
(a) Adjustment for Stock Splits and Combinations. If the Company shall at any time or
from time to time after the Issue Date (or, if this Warrant was issued upon partial exercise of, or
in replacement of, another warrant of like tenor, then the date on which such original warrant was
first issued) (either such date being referred to as the “Original Issue Date”) effect a
subdivision of the outstanding Common Stock, the Purchase Price then in effect immediately before
that subdivision shall be proportionately decreased. If the Company shall at any time or from time
to time after the Original Issue Date combine the outstanding shares of Common Stock, the Purchase
Price then in effect immediately before the combination shall be proportionately increased. Any
adjustment under this Subsection 2(a) shall become effective at the close of business on the date
the subdivision or combination becomes effective.
(b) Adjustment for Certain Dividends and Distributions. In the event the Company at
any time or from time to time after the Original Issue Date shall make or issue, or fix a record
date for the determination of holders of Common Stock entitled to receive, a dividend or other
distribution payable in shares of Common Stock, then and in each such event the Purchase Price then
in effect immediately before such event shall be decreased as of the time of such issuance or, in
the event such a record date shall have been fixed, as of the close of business on such record
date, by multiplying the Purchase Price then in effect by a fraction:
(1) the numerator of which shall be the total number of shares of Common Stock issued and
outstanding immediately prior to the time of such issuance or the
-2-
close of business on such record date, and
(2) the denominator of which shall be the total number of shares of Common Stock issued and
outstanding immediately prior to the time of such issuance or the close of business on such record
date plus the number of shares of Common Stock issuable in payment of such dividend or
distribution;
provided, however, that if such record date shall have been fixed and such dividend
is not fully paid or if such distribution is not fully made on the date fixed therefor, the
Purchase Price shall be recomputed accordingly as of the close of business on such record date and
thereafter the Purchase Price shall be adjusted pursuant to this Subsection 2(b) as of the time of
actual payment of such dividends or distributions.
(c) Adjustment in Number of Warrant Shares. When any adjustment is required to be
made to the Purchase Price pursuant to Subsections 2(a) or 2(b), the number of Warrant Shares
purchasable upon the exercise of this Warrant shall be changed to the number determined by dividing
(i) an amount equal to the number of shares issuable upon the exercise of this Warrant immediately
prior to such adjustment, multiplied by the Purchase Price in effect immediately prior to such
adjustment, by (ii) the Purchase Price in effect immediately after such adjustment.
(d) Adjustment for Reorganization. If there shall occur any reorganization,
recapitalization, reclassification, consolidation or merger involving the Company in which the
Common Stock is converted into or exchanged for securities, cash or other property (other than a
transaction covered by Subsections 2(a) or 2(b)) (collectively, a “Reorganization”), then,
following such Reorganization, the Holder shall receive upon exercise hereof the kind and amount of
securities, cash or other property which the Holder would have been entitled to receive pursuant to
such Reorganization if such exercise had taken place immediately prior to such Reorganization. In
any such case, appropriate adjustment (as determined in good faith by the Board) shall be made in
the application of the provisions set forth herein with respect to the rights and interests
thereafter of the Holder, to the end that the provisions set forth in this Section 2 (including
provisions with respect to changes in and other adjustments of the Purchase Price) shall thereafter
be applicable, as nearly as reasonably may be, in relation to any securities, cash or other
property thereafter deliverable upon the exercise of this Warrant.
(e) No Adjustments in Certain Cases. No adjustment in the number of Warrant Shares
purchasable pursuant to this Warrant shall be required unless the adjustment would require an
increase or decrease of at least one percent (1.0%) in the number of Warrant Shares then
purchasable upon the exercise of this Warrant. Except as provided in this Section 2, no other
adjustments in the number, kind or price of shares constituting Warrant Shares shall be made during
the term, or upon the exercise, of this Warrant. Further, no adjustments shall be made pursuant to
this Section 2 hereof in connection with the grant or exercise of presently authorized or
outstanding options to purchase, or the issuance of shares of Common Stock under, the Company’s
director or employee benefit, option and incentive plans.
(f) Treasury Stock. For purposes of this Section 2, shares of Common Stock owned or
held at any relevant time by, or for the account of, the Company, in its treasury or
-3-
otherwise, shall not be deemed to be outstanding for purposes of the calculations and
adjustments herein described.
4. Investment Representations. The initial Holder represents and warrants to the
Company as follows:
(a) Investment. The Holder is acquiring this Warrant, and (if and when such Holder
exercises this Warrant) will acquire the Warrant Shares, for such Holder’s own account for
investment and not with a view to, or for sale in connection with, any distribution thereof, nor
with any present intention of distributing or selling the same; and the Holder has no present or
contemplated agreement, undertaking, arrangement, obligation, indebtedness or commitment providing
for the disposition thereof.
(b) Accredited Investor. The Holder is an “accredited investor” as defined in Rule
501(a) under the Act.
(c) Experience. The Holder has made such inquiry concerning the Company and its
business and personnel as the Holder has deemed appropriate; and the Holder has sufficient
knowledge and experience in finance and business that the Holder is capable of evaluating the risks
and merits of an investment in the Company.
(a) This Warrant and the Warrant Shares shall not be offered, sold or transferred unless
either (i) they first shall have been registered under the Act and any applicable state securities
laws, or (ii) the Company first shall have been furnished with an opinion of legal counsel,
satisfactory to the Company, to the effect that such offer, sale or transfer is exempt from the
registration requirements of the Act and any applicable state securities laws.
(b) Each Warrant and certificate representing Warrant Shares shall bear a legend substantially
in the following form:
“The securities represented by this certificate have not been registered
under the Securities Act of 1933, as amended, or any state securities laws,
and may not be offered, sold or otherwise transferred, pledged or
hypothecated unless and until such securities are registered under such act
and applicable state securities laws or an opinion of counsel reasonably
satisfactory to the Company is obtained to the effect that such registration
is not required.”
The foregoing legend shall be removed from the certificates representing any Warrant Shares,
at the request of the holder thereof, at such time as they become eligible for resale pursuant to
Rule 144 under the Act.
-4-
(c) The Company will maintain a register containing the name and address of the Holder of this
Warrant. The Holder may change the Holder’s address as shown on the warrant register by written
notice to the Company requesting such change.
(d) Subject to the provisions of clauses (a) and (b) of this Section 5, this Warrant and all
rights hereunder are transferable, in whole or in part, upon surrender of this Warrant with a
properly executed assignment (in the form of Exhibit II hereto) at the principal office of
the Company (or, if another office or agency has been designated by the Company for such purpose,
then at such other office or agency). Upon the presentation and surrender of such items to the
Company, the Company shall execute and deliver to the transferee or transferees of this Warrant a
new Warrant or Warrants, in the name of the transferee or transferees named in the assignment, and
this Warrant shall at that time be canceled to the extent transferred.
(a) The Company will not, by amendment of its charter or through any reorganization, transfer
of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary
action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking
of all such action as may be necessary or appropriate in order to protect the rights of the Holder
against impairment.
(b) Before taking any action that would cause an adjustment reducing the Purchase Price per
share below the then par value of the shares of Warrant Shares issuable upon exercise of the
Warrant, the Company will take any corporate action that may be necessary in order that the Company
may validly and legally issue fully paid and non-assessable shares of such Warrant Shares at such
adjusted price.
(a) the Company shall take a record of the holders of its Common Stock (or other stock or
securities at the time deliverable upon the exercise of this Warrant) for the purpose of entitling
or enabling them to receive any dividend or other distribution, or to receive any right to
subscribe for or purchase any shares of stock of any class or any other securities, or to receive
any other right; or
(b) of any capital reorganization of the Company, any reclassification of the Common Stock of
the Company, any consolidation or merger of the Company with or into another corporation (other
than a consolidation or merger in which the Company is the surviving entity and its Common Stock is
not converted into or exchanged for any other securities or property), or any transfer of all or
substantially all of the assets of the Company; or
(c) of the voluntary or involuntary dissolution, liquidation or winding-up of the Company,
then, and in each such case, the Company will send or cause to be sent to the Holder a notice
specifying, as the case may be, (i) the record date for such dividend, distribution or right, and
the amount and character of such dividend, distribution or right, or (ii) the effective date on
which
-5-
such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or
winding-up is to take place, and the time, if any is to be fixed, as of which the holders of record
of Common Stock (or such other stock or securities at the time deliverable upon the exercise of
this Warrant) shall be entitled to exchange their shares of Common Stock (or such other stock or
securities) for securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, transfer, dissolution, liquidation or winding-up. Such
notice shall be sent at least 10 days prior to the record date or effective date for the event
specified in such notice.
(a) Upon the surrender by the Holder of this Warrant, properly endorsed, to the Company at the
principal office of the Company, the Company will, subject to the provisions of Section 5 hereof,
issue and deliver to or upon the order of the Holder, at the Company’s expense, a new Warrant or
Warrants of like tenor, in the name of the Holder or as the Holder (upon payment by the Holder of
any applicable transfer taxes) may direct, calling in the aggregate on the face or faces thereof
for the number of shares of Common Stock (or other securities, cash and/or property) then issuable
upon exercise of this Warrant.
(b) Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft,
destruction or mutilation of this Warrant and (in the case of loss, theft or destruction) upon
delivery of an indemnity agreement (with surety if reasonably required) in an amount reasonably
satisfactory to the Company, or (in the case of mutilation) upon surrender and cancellation of this
Warrant, the Company will issue, in lieu thereof, a new Warrant of like tenor.
-6-
of the Company or any other matter whatsoever as a stockholder of the Company. In the absence
of affirmative action by the Holder hereof to purchase shares of Common Stock, no provision hereof
shall give rise to any liability of such Holder for the purchase price or as a stockholder of the
Company, whether such liability is asserted by the Company or by creditors of the Company.
17. Governing Law. This Warrant will be governed by and construed in accordance with
the internal laws of the State of Delaware (without reference to the conflicts of law provisions
thereof).
(Signature appears on next page).
-7-
EFFECTIVE as of the Issue Date indicated above.
CYTOCORE, INC. |
|||||
By: | |||||
Title: | |||||
-8-
EXHIBIT I
PURCHASE FORM
To:____________ | Dated:_________ |
The undersigned, pursuant to the provisions set forth in the attached Warrant (No. ___),
hereby elects to purchase ______ shares of the Common Stock of CytoCore, Inc. by such Warrant.
The undersigned herewith makes payment of the full Purchase Price for such shares at the price
per share provided for in such Warrant. Such payment shall be in the aggregate amount of $_________ in
cash, certified or bank check, or wire transfer of immediately available funds.
Signature: | ||||||
Address: | ||||||
-9-
EXHIBIT II
ASSIGNMENT FORM
FOR VALUE RECEIVED, hereby sells, assigns
and transfers all of the rights
of the undersigned under the attached Warrant (No. ___) with respect to the number of shares of
Common Stock of CytoCore, Inc. covered thereby set forth below, unto:
Name of Assignee | Address | No. of Shares | ||
Dated:
|
Signature: | |||||||||
Signature Guaranteed:
|
||||||||||
By: |
||||||||||
The signature should be guaranteed by an eligible guarantor institution (banks, stockbrokers,
savings and loan associations and credit unions with membership in an approved signature guarantee
medallion program) pursuant to Rule 17A under the Securities Exchange Act of 1934, as amended.
-10-